🚀 Hyperliquid Strategies Aims for $1B Boost — Powering the Next Wave of HYPE Token Growth!
Hyperliquid Strategies is making big moves! The firm just filed for a $1 billion capital raise through a committed equity facility with Chardan Capital Markets, setting the stage for major expansion around its HYPE token strategy. 💰🔥
💡 Here’s What’s Happening:
🪙 Up to 160M new shares to be issued via equity facility
💼 Funds expected to fuel HYPE token accumulation and treasury staking
🔄 Formed via merger between Sonnet BioTherapeutics and Rorschach I LLC
📈 Post-merger entity set to list on Nasdaq later this year
👔 Leadership lineup includes Bob Diamond (Chairman) and David Schamis (CEO)
💵 Currently holds $305M in cash and 12.6M HYPE tokens
🔒 Plans to stake most of its token holdings to generate yield
Institutions are clearly taking notice — with Lion Group already rotating Solana and Sui assets into HYPE.
✅ The message is clear: Traditional finance is merging with Web3, and Hyperliquid is leading the charge.
